Insider Trading & Ownership of Jeffrey A. Meckler

Location
San Diego, CA
Summary
The estimated net worth of Jeffrey A. Meckler is at least $2,209,180 dollars as of 13 Feb 2026. Jeffrey A. Meckler is the Director of Travere Therapeutics, Inc. and owns shares of Travere Therapeutics, Inc. (TVTX) stock worth about $1.6M. Jeffrey A. Meckler is the Co-Chief Executive Officer, Director of Indaptus Therapeutics, Inc. and owns shares of Indaptus Therapeutics, Inc. (INDP) stock worth about $605.3K.
Signature
/s/ Jeffrey Meckler
All Insider Reports
All Insider Reports

Follow Filing Activity

Follow Jeffrey A. Meckler and return when a new Insider Trading filing appears.

This tracks SEC filing changes for this page using existing product update flows.

Sign up to follow filing activity

Sponsored

Quick Takeaways

  • Jeffrey A. Meckler has 2 issuer positions tracked on this page.
  • Estimated disclosed ownership value: $2,209,180.
  • Recent insider filing activity is available below.

What Changed

  • Largest disclosed position: Travere Therapeutics, Inc. ($1,603,875).
  • Past-year value change for that position: .

Why This Matters

  • This page translates Forms 3/4/5 into a quick ownership context before you inspect each transaction row.
  • You can cross-check role, issuer, and filing chronology directly against the SEC source.

Official SEC Source

Filed on Form 4

Insider ownership context is sourced from SEC Forms 3, 4, and 5.

See Original Filing

Ownership of Jeffrey A. Meckler

Symbol Company Relationship Holdings Value Past Year Net Change Change % Report Period
TVTX Travere Therapeutics, Inc. Director $1,603,875 15 May 2025
INDP Indaptus Therapeutics, Inc. Co-Chief Executive Officer, Director $605,305 11 Feb 2026

Insider Transactions Reported by Jeffrey A. Meckler:

Sym Company Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Sponsored